Intralesional Sclerotherapy - A Novel Approach for The Treatment of Intraoral Haemangiomas

• Main Authors: G.SIVA PRASAD REDDY, G.VENKATESHWARA REDDY, K.SRAVAN KUMAR REDDY, B.SRILATHA PRIYADARSHINI, P.KARUNA SREE
• Format: Article
• Language: English
• Published: JCDR Research and Publications Private Limited 2016-01-01
• Series: Journal of Clinical and Diagnostic Research
• Subjects: sodium tetra decyl sulphate; sclerosing agent; vascular lesions
• Online Access: https://jcdr.net/articles/PDF/7137/17568_CE[Ra1]_F(AK)_PF1(EKAK)_PFA(AK)_PF2(PAG).pdf

In infancy and childhood haemangiomas are the most common neoplasms in head and neck region with an occurrence of about 60%. Approximately 40%-50% of all haemangiomas resolve incompletely, leaving permanent changes in the skin, such as telangiectases, epidermal atrophy, hypopigmentation or redundant skin with fibro-fatty residue but a few stubborn, problematic haemangiomas may result in serious disfigurement and dysfunction, and even become life-threatening. Most haemangiomas are managed by conservative methods that include corticosteroids (either systemic or local injection), sclerotherapy, interferon-alpha, laser therapy, embolization, cryotherapy, and radiation. Due to risk of haemorrhaging, surgical removal for small vascular lesions is not considered and it is more invasive than sclerotherapy. This case report presents the efficacy of intralesional sclerotherapy for the management of haemangiomas on dorsum and lateral border of tongue.